V. Savci et al., INTRACEREBROVENTRICULAR INJECTION OF CHOLINE INCREASES PLASMA OXYTOCIN LEVELS IN CONSCIOUS RATS, Brain research, 709(1), 1996, pp. 97-102
In the present study, we examined the effect of intracerebroventricula
rly (i.c.v.) injected choline on both basal and stimulated oxytocin re
lease in conscious rats. I.c.v. injection of choline (50-150 mu g) cau
sed time- and dose-dependent increases in plasma oxytocin levels under
normal conditions. The increase in plasma oxytocin levels in response
to i.c.v. choline (150 mu g) was greatly attenuated by the pretreatme
nt of rats with atropine (10 mu g; i.c.v.), muscarinic receptor antago
nist. Mecamylamine (50 mu g; i.c.v.), a nicotinic receptor antagonist,
failed to suppress the effect of 150 mu g choline on oxytocin levels.
Pretreatment of rats with 20 mu g of hemicholinium-3 (HC-3), a specif
ic inhibitor of choline uptake into nerve terminals, greatly attenuate
d the increase in plasma oxytocin levels in response to i.c.v. choline
injection. Osmotic stimuli induced by either oral administration of 1
mi hypertonic saline (3 M) following 24-h dehydration of rats (type 1
) or an i.c.v. injection of hypertonic saline (1 M) (type 2) increased
plasma oxytocin levels significantly, but hemorrhage did not alter ba
sal oxytocin concentrations. The i.c.v. injection of choline (50, 150
mu g) under these conditions caused an additional and significant incr
ease in plasma oxytocin concentrations beyond that produced by choline
in normal conditions. These data show that choline can increase plasm
a oxytocin concentrations through the stimulation of central cholinerg
ic muscarinic receptors by presynaptic mechanisms and enhance the stim
ulated oxytocin release.